Skip to main content

Pros and cons of sequencing and combinations in Immunotherapy

By 18 Dicembre 2018Aprile 7th, 2021No Comments
Congressi

At Immunotherapy and Melanoma Bridge congress in Naples we interviewed Robert L. Ferris, Director of the UPMC Hillman Cancer Center on the ongoing debate about sequencing and combinations in Immunotherapy.